Last €40.34 EUR
Change Today -0.237 / -0.58%
Volume 45.0
As of 7:19 AM 07/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

William J. Chase

Chief Financial Officer and Executive Vice President, AbbVie Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

46$5,112,723
As of Fiscal Year 2013

Background*

Mr. William J. Chase, also known as Bill serves as the Chief Financial Officer and Executive Vice President at AbbVie Inc. Mr. Chase served as a Vice President of Licensing & Acquisitions at Abbott Laboratories. Mr. Chase served more than 20 years in various capacities at Abbott, including as Abbott's Vice President, Licensing and Acquisitions since 2010 and as Abbott's Treasurer.

Corporate Headquarters*

1 North Waukegan Road
North Chicago, Illinois 60064

United States

Phone: 847-932-7900
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

Salary$790,000
Total Annual Compensation$790,000

Stock Options*

Restricted Stock Awards$2,034,396
All Other Compensation$76,788
Exercised Options12,179
Exercised Options Value$172,475
Exercisable Options85,996
Unexercisable Options135,229
Total Value of Options$172,475
Total Number of Options233,404

Total Compensation*

Total Annual Cash Compensation$1,966,788
Total Short Term Compensation$790,000
Other Long Term Compensation$2,111,184
Total Calculated Compensation$5,112,723
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4AB:GR €40.34 EUR -0.237

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
Miles D. White Chairman, Chief Executive Officer and Chairman of Executive Committee
Abbott Laboratories
$1.9M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Lars Rebien Sørensen Chief Executive Officer
Novo Nordisk A/S
kr15.2M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ABBVIE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.